Assignee
MEDIGENE AG
DE·32 granted patents·17 pending applications·971 citations·filing 1997–2019
Top patents by PatentIndex Score
49 records- 0196US7968340B2Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2009·Granted Jun 28, 2011·88 cites·8 claims
- 0294US6207453B1Recombinant AAV vector-based transduction system and use of sameMEDIGENE AG·Filed 1997·Granted Mar 27, 2001·299 cites·13 claims
- 0393US9624274B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2012·Granted Apr 18, 2017·79 cites·16 claims
- 0493US7252997B1Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2000·Granted Aug 7, 2007·66 cites·8 claims
- 0593US7001765B2Adeno-associated virus vector for boosting immunogenicity of cellsMEDIGENE AG·Filed 2003·Granted Feb 21, 2006·61 cites·11 claims
- 0692US6846665B1Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicamentMEDIGENE AG·Filed 2000·Granted Jan 25, 2005·51 cites·27 claims
- 0791US7556965B2Structural protein of adeno-associated virus with modified antigenicity, its production and its useMEDIGENE AG·Filed 2007·Granted Jul 7, 2009·28 cites·8 claims
- 0888US7285381B1Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2000·Granted Oct 23, 2007·30 cites·28 claims
- 0987US9060998B2Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skinMEDIGENE AG·Filed 2013·Granted Jun 23, 2015·20 cites·15 claims
- 1086US6649167B2Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted Nov 18, 2003·29 cites·13 claims
- 1185US7314912B1AAv scleroprotein, production and use thereofMEDIGENE AG·Filed 1999·Granted Jan 1, 2008·92 cites·15 claims
- 1281US9238021B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2014·Granted Jan 19, 2016·2 cites·26 claims
- 1376US7858662B2Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2002·Granted Dec 28, 2010·9 cites·25 claims
- 1476US7794747B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2004·Granted Sep 14, 2010·6 cites·22 claims
- 1576US7618452B2Artificially produced, three-dimensional muscle tissueMEDIGENE AG·Filed 2001·Granted Nov 17, 2009·6 cites·15 claims
- 1676US7494658B2Papilloma virus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2005·Granted Feb 24, 2009·2 cites·10 claims
- 1776US7182947B2Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2003·Granted Feb 27, 2007·7 cites·15 claims
- 1875US6838272B2Filtration process for separating virusesMEDIGENE AG·Filed 2002·Granted Jan 4, 2005·4 cites·38 claims
- 1975US6352696B1Papillomavirus truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted Mar 5, 2002·29 cites·13 claims
- 2070US6479273B1Filtration method for separating virusesMEDIGENE AG·Filed 1998·Granted Nov 12, 2002·25 cites·38 claims
- 2169US6440742B1Recombinant AAV vector-based transduction system and use of sameMEDIGENE AG·Filed 2001·Granted Aug 27, 2002·4 cites·7 claims
- 2268US2011052617A1Aav scleroprotein, production and use thereofMEDIGENE AG·Filed 2009·Application pending·0 cites
- 2366US7078543B2Methods for producing oxirane carboxylic acids and derivatives thereofMEDIGENE AG·Filed 2002·Granted Jul 18, 2006·7 cites·13 claims
- 2466US6838084B1Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapyMEDIGENE AG·Filed 2000·Granted Jan 4, 2005·5 cites·1 claims
- 2566US2020191788A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 2661US2007238684A1AAV scleroprotein, production and use thereofMEDIGENE AG·Filed 2006·Application pending·0 cites
- 2759US2020054552A1Medicament for the treatment of viral skin and tumour diseasesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 2859US2010178243A1Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier systemMEDIGENE AG·Filed 2009·Application pending·0 cites
- 2958US10822378B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2017·Granted Nov 3, 2020·0 cites·16 claims
- 3057US2010203083A1Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2008·Application pending·0 cites
- 3155US2018265514A1Salt of cd80 antagonistMEDIGENE AG·Filed 2017·Application pending·0 cites
- 3255US2010105123A2Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the sameMEDIGENE AG·Filed 2007·Application pending·0 cites
- 3354US7932253B2Immunomodulating oxopyrrazolocinnolines as CD80 inhibitorsMEDIGENE AG·Filed 2004·Granted Apr 26, 2011·0 cites·4 claims
- 3454US6562351B2Papilloma truncated L1 protein and fusion protein constructsMEDIGENE AG·Filed 2001·Granted May 13, 2003·10 cites·16 claims
- 3554US2010034796A1Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunctionMEDIGENE AG·Filed 2009·Application pending·0 cites
- 3653US7910138B2Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skinMEDIGENE AG·Filed 2004·Granted Mar 22, 2011·0 cites·16 claims
- 3753US2013288921A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2013·Application pending·0 cites
- 3852US6926897B1Medicament for the avoidance or treatment of papillomavirus-specific tumourMEDIGENE AG·Filed 2000·Granted Aug 9, 2005·0 cites·18 claims
- 3950US10408834B2Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2015·Granted Sep 10, 2019·0 cites·24 claims
- 4050US6171597B1Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cellsMEDIGENE AG·Filed 1997·Granted Jan 9, 2001·6 cites·10 claims
- 4150US2009317456A1Use of oncolytic viruses and antiangiogenic agents in the treatment of cancerMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4249US6448074B1Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cellsMEDIGENE AG·Filed 2000·Granted Sep 10, 2002·0 cites·10 claims
- 4347US2010297214A1Percolative drying for the preparation of particlesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4447US2010316696A1Liposome preparation by single-pass processMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4546US6294370B1System for the production of AAV vectorsMEDIGENE AG·Filed 1997·Granted Sep 25, 2001·6 cites·22 claims
- 4646US2010034749A1Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular DiseasesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4746US2011002851A1Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory DiseasesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4843US2002039584A1Papilloma virus capsomere vaccine formulations and methods of useMEDIGENE AG·Filed 2001·Application pending·0 cites
- 4941US2011212072A1Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial DysfunctionMEDIGENE AG·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →